Table 1. HDAC inhibition IC50 and Ki for the five LOPAC hit compounds.
Ebselen | NSC-95397 | U-73122 | GNTI | Aurothioglucose | ||||||
---|---|---|---|---|---|---|---|---|---|---|
IC50 | Ki | IC50 | Ki | IC50 | Ki | IC50 | Ki | IC50 | Ki | |
HDAC1 | 1.5 ± 0.4 | 0.15 | >180 | N/A | 38.4 ± 15.5 | 4.11 | 30.2 ± 7.3 | 3.24 | 4.4 ± 1.1 | 0.47 |
HDAC2 | 1.4 ± 0.3 | 0.08 | >100 | N/A | >100 | N/A | 26.2 ± 7.6 | 1.48 | >180 | N/A |
HDAC3 | 2.1 ± 1.5 | 0.23 | >100 | N/A | 6.2 ± 4.0 | 0.66 | 22.7 ± 3.1 | 2.43 | 11.5 ± 3.2 | 1.23 |
HDAC4 | 1.2 ± 0.2 | 0.20 | 7.2 ± 2.8 | 1.23 | 31.2 ± 0.2 | 5.33 | 13.4 ± 1.6 | 2.29 | 4.1 ± 2.1 | 0.7 |
HDAC5 | 0.78 ± 0.1 | 0.42 | 3.1 ± 0.2 | 1.68 | 10.5 ± 7.4 | 5.68 | 0.70 ± 0.1 | 0.38 | 0.72 ± 0.5 | 0.39 |
HDAC6 | 12.8 ± 2.6 | 3.10 | 12.7 ± 2.5 | 3.07 | 45.2 ± 12.6 | 10.96 | >180 | N/A | 14.4 ± 5.8 | 3.49 |
HDAC7 | 10.9 ± 2.2 | 3.09 | 13.1 ± 4.3 | 3.72 | >180 | N/A | 18.9 ± 1.0 | 5.36 | 22.4 ± 4.4 | 6.35 |
HDAC8 | 0.35 ± 0.2 | 0.11 | 1.3 ± 0.1 | 1.03 | 10.9 ± 3.1 | 8.63 | 2.0 ± 0.4 | 1.58 | 1.4 ± 0.3 | 1.11 |
HDAC9 | 0.97 ± 0.5 | 0.20 | 4.8 ± 1.4 | 2.04 | 29.8 ± 5.6 | 12.67 | 12.3 ± 1.7 | 5.23 | 2.8 ± 0.1 | 1.19 |
HDAC10 | 0.95 ± 0.4 | 0.42 | 14.5 ± 1.5 | 6.40 | >100 | N/A | >180 | N/A | 4.9 ± 1.5 | 2.16 |
HDAC11 | 22.5 ± 2.4 | 4.41 | 37.8 ± 1.4 | 7.41 | >180 | N/A | >180 | N/A | >180 | N/A |